| Metric | Nov 19, 2024 FY24 Q4 | Jan 30, 2025 FY25 Q1 | May 6, 2025 FY25 Q2 | Aug 5, 2025 FY25 Q3 | Nov 20, 2025 FY25 Q4 | Feb 3, 2026 FY26 Q1 | May 5, 2026 FY26 Q2 | Aug 4, 2026 FY26 Q3 |
|---|---|---|---|---|---|---|---|---|
| For FY2026 | ||||||||
| Adjusted net revenue growth | — | — | — | — | New“grow 6% to 10% over fiscal 2025” | Changed“6.5% to 10.0% over fiscal 2025” | Changed“8.0% to 10.5%” | Narrowed“9.5% to 10.0%” |
| Adjusted EBITDA margin | — | — | — | — | New“14.4% to 14.7%” | Reiterated“14.4% to 14.7%” | Raised“14.6% to 14.9%” | Narrowed“14.7% to 14.8%” |
| Adjusted EPS | — | — | — | — | New“$6.90 to $7.30” | Narrowed“$6.95 to $7.30” | Raised“$7.10 to $7.35” | Narrowed“$7.20 to $7.30” |
| Adjusted EPS Growth, at Midpoint | — | — | — | — | New“16% Growth” | — | — | — |
| Adjusted free cash flow margin | — | — | — | — | — | — | New“7.0% to 8.5%” | Narrowed“approximately 8%” |
| Free cash flow margin | — | — | — | — | New“7.0% to 8.0%” | Widened“7.0% to 8.5%” | — | — |
| For FY2025 | ||||||||
| Adjusted net revenue growth | — | — | — | New“approximately 5.5% over fiscal 2024” | — | — | — | — |
| Adjusted net revenue growth | New“mid-to-high single digits over fiscal 2024” | Reiterated“mid-to-high single digits over fiscal 2024” | Reiterated“grow mid-to-high single digits over fiscal 2024” | — | — | — | — | — |
| Adjusted EBITDA margin | New“13.8-14.0%” | Reiterated“13.8-14.0%” | Reiterated“13.8-14.0%” | Narrowed“approximately 13.9%” | — | — | — | — |
| Adjusted EPS | New“$5.80-$6.20” | — | — | — | — | — | — | — |
| Adjusted EPS range | — | New“$5.85-$6.20” | Reiterated“$5.85-$6.20” | Narrowed“$6.00-6.10” | — | — | — | — |
| Annual margin expansion target | — | — | — | — | New“50-80 basis point” | — | — | — |
| Reported free cash flow (FCF) conversion | New“exceed 100% of net income” | Reiterated“exceed 100% of net income” | Reiterated“exceed 100% of net income” | Reiterated“exceed 100% of net income” | — | — | — | — |
| No period stated | ||||||||
| Adjusted EBITDA margin | — | — | — | — | — | — | New“14.4% to 14.7%” | Raised“14.6% to 14.9%” |
| Adjusted EPS | — | — | — | — | — | New“$6.90 to $7.30” | Narrowed“$6.95 to $7.30” | Raised“$7.10 to $7.35” |
| Adjusted free cash flow margin | — | — | — | — | — | — | — | New“7.0% to 8.5%” |
| Free cash flow margin | — | — | — | — | — | New“7.0% to 8.0%” | — | — |
| Cost Synergy Estimate | — | — | — | — | — | — | New“$20 million+” | — |
| Net leverage ratio | — | — | — | New“1.0-1.5x target range” | — | — | — | — |
| PA Consulting cost synergies | — | — | — | — | — | — | New“at least $20 million per year” | — |
| Quarterly dividend | — | New“$0.32/share” | — | — | — | — | — | — |
| Share repurchase program authorization | — | New“$1.5 Billion” | — | — | — | — | — | — |